Stenabolic raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-09-20. Anything still debated is marked as such rather than presented as settled.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Derived from published structure. |
| Molecular weight | 437.94 g/mol | Calculated value. |
| Appearance | White to off-white solid | Typical for purified research samples. |
| Solubility | DMSO, ethanol; low in water | Class: poorly water-soluble. |
| Typical storage | -20 °C, desiccated, protected from light | Limits degradation. |
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
== Analysis == A wide variety of techniques can be used to analyze the interfacial layer, often SAXS, NMR, AFM, STM are used, but other methods, like measuring the refractive index can reveal information as well. Small-angle X-ray diffraction provides data about the size and dispersion of the nanoparticles, and gives information about the density of the interfacial layer. Because the amount of scattering is proportionate with the density. On top of this the thickness of the layer can be estimated. However a disadvantage is that SAXS is destructive. AFM and STM measurements can reveal information at atomic resolution about the structure and shape of the interfacial layer. This information is limited to the surface of the nanoparticle, as you can only probe the surface. Another drawback of STM is that it's only applicable if the interfacial layer is conducting. (Solid-state) NMR can be used to study the composition, short range ordering and dynamics in the interfacial layer. The dynamics can be studied over a wide range of timescales, which allows the intermolecular interactions, chemical reactions and transport phenomena to be analyzed.
=== 1990s === In the fall of 1990, Kidder appeared as a singer who becomes a murder victim in the Canadian television film White Room (1990). After her car accident, Kidder returned to the screen with an uncredited cameo appearance in the comedy film Delirious (1991), appearing as a woman in a washroom. This was followed by a role as a psychic in To Catch a Killer (1992), a Canadian television thriller film based on the crimes of John Wayne Gacy. She had several small roles in 1994, including in the Disney Channel film Windrunner, as well as another uncredited appearance in Maverick. She played a bartender at the Broken Skull Tavern in Under a Killing Moon, a PC FMV adventure game. Kidder returned to film with a lead role in the independent comedy-drama Never Met Picasso (1997), portraying an actress living with her gay adult son (portrayed by Alexis Arquette), who is attempting to sort his life out. Kevin Thomas of the Los Angeles Times wrote, "Arquette and Kidder [were] given the chance to come across as quite appealing" in their roles. She next appeared in the slasher film The Clown at Midnight (1998), opposite Christopher Plummer, and alongside Lynn Redgrave and James Earl Jones in the romance film The Annihilation of Fish (1999), playing the landlady of an interracial couple. Critic Todd McCarthy in Variety referred to the film as a "would-be charmer" and "a drear moment in the careers of all concerned."
=== Awards === The Orange Box won a number of awards for its overall high standard and use of technology. The compilation won "Computer Game of the Year" at the Academy of Interactive Arts & Sciences' 11th Annual Interactive Achievement Awards; it also received nominations in the "Overall Game of the Year", "Action Game of the Year", and "Outstanding Innovation in Gaming" categories. The Orange Box won the "Breakthrough Technology Award" and the "Best PC Game Award" at the 2007 Spike Video Game Awards, and was additionally nominated in the "Game of the Year", "Best Shooter", "Best Xbox 360 Game", and "Best Multiplayer Game" categories. It was also named the second-best video game of 2007 by Time Magazine, while the PlayStation 3 version was nominated in the category of Action and Adventure at the BAFTA Video Games Awards. Valve also received developer awards for their work on The Orange Box. The Orange Box received 17 Game of the Year awards and over 100 awards in total. The Orange Box was placed as the 22nd most influential video game in history by the Guinness World Records Gamer's Edition, 2009. Portal won "Outstanding Achievement in Game Design", "Outstanding Achievement in Gameplay Engineering", and "Outstanding Character Performance" for Ellen McLain's vocal portrayal of GLaDOS at the 11th Annual Interactive Achievement Awards. The game won 76 awards, including 37 Game of the Year awards, and was recognized for innovative design and game mechanics. The dark humor of Portal and the ending music track "Still Alive" were also singled out for awards.
Sources: en.wikipedia.org
=== 1970s === 1971: introduces the original Millex syringe filter—the first disposable syringe filter 1972: opens subsidiary in Spain 1972: opens a manufacturing plant in Jaffrey, New Hampshire. 1973: starts manufacturing in Molsheim, France 1973: introduces the Milli-Q water purification system, the first lab-scale ultrapure water system 1978: reaches $100 million revenue 1978: opens manufacturing plant in Danvers, Massachusetts 1979: acquires Waters Associates Inc., a producer of chromatographic media and High-performance liquid chromatography instrumentation
=== Mechanism === Natriuretic peptides and their receptors have many different effects on the body, such as controlling blood pressure and helping bones grow. Each peptide has its own unique effects and interacts with specific receptors. Scientists have observed these effects by studying mice with specific natriuretic peptides or receptors removed. Natriuretic peptides have a wide range of physiological effects that include the regulation of blood pressure, fluid and electrolyte balance, and cardiovascular function. They are also involved in the regulation of vascular remodeling, inflammation, and apoptosis. One of the major clinical applications of natriuretic peptides is the diagnosing and managing of heart failure. Elevated levels of ANP and BNP are commonly found in patients with heart failure and can be used as biomarkers for the diagnosis and prognosis of this condition.
=== Money laundering === Although Mexican drug cartels and their Colombian suppliers generate and launder between $18 billion to $39 billion from sales to the United States each year, the U.S. and Mexican governments have been criticized for their unwillingness or slow response to confront the various cartels' financial operations, including money laundering. The U.S. DEA has identified the need to increase financial investigations relating to the movement of illegal drug funds to Mexico. The DEA has noted that the U.S. and Mexican financial services industry continues to be a facilitator for money laundering. In August 2010, President Felipe Calderón proposed new measures to combat cash smuggling and money laundering. Calderón proposed a ban on cash purchases of real estate and of certain luxury goods that cost more than 100,000 pesos (about US$8,104). His package would also require more businesses to report large transactions, such as real estate, jewelry and purchases of armor plating. In June 2010, Calderón announced strict limits on the amount in U.S. dollars that can be deposited or exchanged in banks, but the restrictions were relaxed in 2014. In 2011, Wachovia, at one time a major U.S. bank, was implicated in laundering money for Mexican drug traffickers. In a settlement, Wachovia paid federal authorities $110 million in forfeiture. A U.S. Senate report from the permanent subcommittee for investigations revealed in July 2012 that HSBC moved $7 billion in bulk cash from Mexico to the U.S., most of it suspected to assist Mexican cartels and U.S.
Sources: en.wikipedia.org
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.
No. SR9009 targets the nuclear receptors REV-ERBα and REV-ERBβ, not the androgen receptor. This mechanism differs from selective androgen receptor modulators and from exercise mimetics that act on PPARδ.
Published evidence is mainly preclinical, using cell cultures and animal models. Controlled human trials are not well documented in the public literature. Claims about human performance or health effects therefore remain unsupported by robust clinical data.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.